Treatment of severe pemphigus foliaceus with rituximab

Medical Journal of Australia

Volumn 189, Issue 5, 2008, Pages 289-290

  Fernando, Suran L ^a   O'Connor, Kate S ^b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEMPHIGUS ANTIBODY; PREDNISONE; RITUXIMAB;

ACANTHOLYSIS; ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BLISTER; CASE REPORT; CATHETER INFECTION; CITROBACTER KOSERI; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MALE; NONHUMAN; OFF LABEL DRUG USE; PEMPHIGUS FOLIACEUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMAPHERESIS; SAMOA; SEPSIS; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; SUPERINFECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HUMANS; IMMUNOLOGIC FACTORS; MALE; PEMPHIGUS;

EID: 53349110013     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb02030.x     Document Type: Article

References (8)

1. Stanley JR, Amagai M. Pemphigus, bullous impetigo and Staphylococcal scalded skin syndrome. N Engl J Med 2006; 355: 1800-1810.
2. Gniadecki R. Desmoglein autoimmunity in the pathogensis of pemphigus. Autoimmunity 2006; 39: 541-547.
3. Wood AJ, Wood MD. Management of acquired bullous skin diseases. N Engl J Med 1995; 333: 1475-1484.
4. Dick SE, Werth VP. Pemphigus: a treatment update. Autoimmunity 2006; 39: 591-599.
5. Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 2006; 5: 564-576.
6. Edwards JC, Cambridge G. Prospects for B-cell-targeted therapy in autoimmune disease. Rheumatology 2005; 44: 151-156.
7. Joly P, Mouquet H, Roujeau JC, et al. Single cycle of Rituximab for the treatment of severe pemphigus. N Engl J Med 2007; 357: 545-552.
8. Sharma R, Koller L, Barcaly F, Liddle C. Evaluation of the off-label usage of Rituximab in a large teaching hospital in New South Wales. Intern Med J 2007; 37: 569-571.